JPH03247335A - Emergency adhesive bandage - Google Patents
Emergency adhesive bandageInfo
- Publication number
- JPH03247335A JPH03247335A JP41048790A JP41048790A JPH03247335A JP H03247335 A JPH03247335 A JP H03247335A JP 41048790 A JP41048790 A JP 41048790A JP 41048790 A JP41048790 A JP 41048790A JP H03247335 A JPH03247335 A JP H03247335A
- Authority
- JP
- Japan
- Prior art keywords
- drug
- pad
- blister
- protrusion
- sheet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000853 adhesive Substances 0.000 title claims abstract description 15
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 57
- 229940079593 drug Drugs 0.000 claims abstract description 56
- 239000011248 coating agent Substances 0.000 claims description 20
- 238000000576 coating method Methods 0.000 claims description 20
- 230000035876 healing Effects 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 description 17
- 208000027418 Wounds and injury Diseases 0.000 description 17
- 239000012528 membrane Substances 0.000 description 6
- 239000000645 desinfectant Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- SIACJRVYIPXFKS-UHFFFAOYSA-N (4-sulfamoylphenyl)methylazanium;chloride Chemical compound Cl.NCC1=CC=C(S(N)(=O)=O)C=C1 SIACJRVYIPXFKS-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- OJFZXRZZXBFEAP-UHFFFAOYSA-N 5-chloro-1,6-dimethylcyclohexa-2,4-dien-1-ol Chemical compound ClC=1C(C(C=CC1)(C)O)C OJFZXRZZXBFEAP-UHFFFAOYSA-N 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- ITRJWOMZKQRYTA-RFZYENFJSA-N Cortisone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)CC2=O ITRJWOMZKQRYTA-RFZYENFJSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- DJDFFEBSKJCGHC-UHFFFAOYSA-N Naphazoline Chemical compound Cl.C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 DJDFFEBSKJCGHC-UHFFFAOYSA-N 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229960002645 boric acid Drugs 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 229960003290 cortisone acetate Drugs 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 229960001378 dequalinium chloride Drugs 0.000 description 1
- LTNZEXKYNRNOGT-UHFFFAOYSA-N dequalinium chloride Chemical compound [Cl-].[Cl-].C1=CC=C2[N+](CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)=C(C)C=C(N)C2=C1 LTNZEXKYNRNOGT-UHFFFAOYSA-N 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003657 dexamethasone acetate Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960002534 ephedrine hydrochloride Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000011086 glassine Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 229960004760 naphazoline hydrochloride Drugs 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960002800 prednisolone acetate Drugs 0.000 description 1
- 229960001309 procaine hydrochloride Drugs 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- YZMCKZRAOLZXAZ-UHFFFAOYSA-N sulfisomidine Chemical compound CC1=NC(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 YZMCKZRAOLZXAZ-UHFFFAOYSA-N 0.000 description 1
- 229960001975 sulfisomidine Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229960002494 tetracaine hydrochloride Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
[0001] [0001]
本発明は殺菌消毒剤等の薬剤を包含する救急絆創膏に関
する。
[0002]TECHNICAL FIELD The present invention relates to an emergency bandage containing a drug such as a germicidal disinfectant. [0002]
一般に繁用の簡易救急絆創膏は、殺菌消毒剤、創傷治療
剤を含浸させたガーゼを通気孔を有する粘着性のシート
に装着し、使用時に裏面の剥離紙を剥がして前記ガーゼ
を傷口局所に当てて使用するようにしたものである。
[0003]
しかしながら、これらの従来品においては、予めガーゼ
に薬液を含浸させておくため、経時的に薬液が蒸散し、
また効力の失活をきたすばかりでなく、局所への当接に
際してはガーゼ部が乾燥状態となっているため、傷口を
いためる恐れがあり、使用に際しても、痛みを感じさせ
る等の欠点があった。
[0004]
また、薬剤被覆膜により薬剤をシールしたブリスター部
を有する救急絆創膏であって、使用に際してブリスター
部を指で押圧して薬剤被覆膜を破壊することにより薬剤
をパッドに含浸させるものも知られている(実公昭54
−23197号公報、米国特許第3297032号明細
書)。
[0005]A commonly used simple emergency bandage is made by attaching gauze impregnated with a sterilizing disinfectant or wound treatment agent to an adhesive sheet with ventilation holes, and when in use, peel off the release paper on the back and apply the gauze to the wound. It is designed to be used in [0003] However, in these conventional products, because the gauze is impregnated with a chemical solution in advance, the chemical solution evaporates over time.
In addition, not only does it lose its effectiveness, but the gauze part is dry when applied to the local area, so there is a risk of damaging the wound, and there are disadvantages such as making people feel pain when using it. . [0004] Also, an emergency bandage having a blister portion in which a drug is sealed with a drug coating film, and in use, the pad is impregnated with the drug by pressing the blister portion with a finger to break the drug coating film. is also known (Jikko 54)
-23197, U.S. Pat. No. 3,297,032). [0005]
しかしながら、この型の救急絆創膏は、ブリスター部が
平滑な表面を有するものであるため、これを押圧した時
、力がブリスター部全体に分散し、押圧部全体が不規則
に窪んでしまう。このため、ブリスター部が薬剤被覆膜
に到達してこれを破壊することは非常に困難であった。
[0006]
また、たとえブリスター部の内部圧力の上昇によって薬
剤被覆膜が破壊された場合でも、破壊箇所はブリスター
部と薬剤被覆膜の接線部分となり、薬剤がパッド外縁部
またはパッド外に移動し、その効果が損なわれるという
問題があった。
[0007]
また、米国特許第4117841号明細書には、接着剤
が塗布された絆創膏ストリップの中央部下表面に薬剤を
保持する空間を形成して液体不浸透性のシート(あるい
は液体不浸透性層を介して液体浸透性のシート)を設け
、該空間内の絆創膏ストリップの下表面にプラスチック
の歯のような突起体を設け、また該空間内に薬剤を充填
した絆創膏について記載されている。
[0008]
この絆創膏は、使用に際し、指により前記シートを突起
体に押しつけ、シートを破壊して薬剤を傷口に直接垂ら
した後、絆創膏を傷口に適用するものであるが指により
シートを突起体に押しつけシートを破壊する操作は、突
起体の先鋭部分により指を傷め、または傷つける恐れが
あり、またシートの破壊時に一部の薬液が指に付着し、
さらにその後薬液を傷口に垂らす際に一部の薬液が傷口
から滴り落ちて薬液が無駄になる。また、この絆創膏の
基本的欠点として、絆創膏′は突起体が残存したまま、
かつ、その先鋭部分が傷口に向かった状態で傷口に適用
されるので、突起体により傷を一層いためる危険性があ
り、そうでなくても使用感が極めて悪いという欠点を有
するものである。
[0009]
本発明は上記した従来技術の欠点を解決したものである
。
[0010]However, in this type of emergency bandage, the blister part has a smooth surface, so when the blister part is pressed, the force is dispersed over the entire blister part, and the entire pressing part becomes irregularly depressed. For this reason, it was very difficult for the blister portion to reach and destroy the drug-coated membrane. [0006] Furthermore, even if the drug coating film is destroyed due to an increase in the internal pressure of the blister part, the breakage point will be a tangent between the blister part and the drug coating film, and the drug will move to the outer edge of the pad or outside the pad. However, there was a problem that the effect was impaired. [0007] US Pat. No. 4,117,841 discloses that a liquid-impermeable sheet (or liquid-impermeable layer) is formed by forming a drug-holding space on the central lower surface of an adhesive-coated bandage strip. A bandage is described in which a liquid-permeable sheet is provided through the bandage, a plastic tooth-like protrusion is provided on the lower surface of the bandage strip in the space, and a drug is filled in the space. [0008] When using this bandage, the sheet is pressed against the protrusion with a finger, the sheet is broken and the medicine is dripped directly onto the wound, and then the bandage is applied to the wound. The operation of destroying the sheet by pressing it against the surface may damage or injure your fingers due to the sharp parts of the protrusions, and some of the chemical solution may adhere to your fingers when the sheet is destroyed.
Furthermore, when the medicinal solution is subsequently applied to the wound, some of the medicinal solution drips from the wound and is wasted. In addition, the basic drawback of this bandage is that the bandage remains with protrusions.
In addition, since it is applied to a wound with its sharp point facing the wound, there is a risk that the protrusion will further damage the wound, and even if this is not the case, it has the disadvantage of being extremely uncomfortable to use. [0009] The present invention solves the above-described drawbacks of the prior art. [0010]
すなわち、本発明の救急絆創膏は、パッドを装着した粘
着シートと剥離シートとからなり、該剥離シートには、
薬剤被覆膜によりその下面がシールされ、かつ薬剤を包
含するブリスター部が前記パッド上に位置して設けられ
ており、該ブリスター部には凹状の突起が設けられてい
ることを特徴とする。
[0011]
本発明の救急絆創膏は、使用に際してブリスター部を指
で押圧してブリスター部の凹状突起により薬剤被覆膜を
破壊し、薬剤をパッドに移動させるものであるが、ブリ
スター部の押圧操作はブリスター部の凹状突起の窪み部
分に指をかけて行うため非常に操作がしやすく、そして
突起部分は形状的にその周辺部分より硬いため、これを
上方より押圧すれば突起部分はその形状が壊れることな
く薬剤被覆膜に到達し、その所望の場所、一般的にはパ
ッドの中央部に対応する箇所の薬剤被覆膜を容易に、カ
リ確実に破壊することができ、従って薬剤はパッドの所
望の場所に無駄なく確実に移動する。
[0012]
このようにして、薬剤をパッドに移動させた後、薬剤被
覆膜および凹状突起が設けられているブリスター部を有
する剥離シートは粘着シートから除去される。
そして、傷口には薬剤の付いたパッドを有する粘着シー
トのみが適用されるので使用上の危険性や違和感がない
。
[0013]
本発明に使用する薬剤については、殺菌消毒剤としてグ
ルコン酸クロルヘキシジン、塩化ベンザルコニウム、ク
ロルキシレノール、アクリノール、チアントール、塩化
デカリニウム、スルフイソミジン、スルファミン、ニト
ロフラゾン、ホウ酸、ホモスルファミン、トリクロカル
パン等があり、創傷部収斂治癒促進剤として酸化亜鉛、
塩酸ピリドキシン、酢酸トコフェロール、シバルミチン
酸ピリドキシン等、止血剤としては塩酸ナファゾリン、
硫酸亜鉛、塩酸エフェドリン等、抗炎症剤としてはプレ
ドニゾロン、デキサメサゾン、酢酸コルチゾン等のステ
ロイド剤、グリチルレチン、塩化リゾチーム等、抗ヒス
タミン剤としてマレイン酸クロルフェニラミン、塩酸ジ
フェンヒドラミン等がある。
[0014]
また、局麻剤としてはりドカイン、アミノ安息香酸エチ
ル、塩酸プロカイン、塩酸ジプカイン、塩酸テトラカイ
ン、塩酸バラブチルアミノ安息香酸ジエチルアミノアチ
ル等がある。
[0015]
これらの薬剤は目的に合わせ、単味でまたは複数の配合
剤とすることができ、また、薬剤の性状は溶液状の他、
軟膏状、グリース状、粉末等流動性のあるものであれば
いかなる性状でもよい。
[0016]
粘着シートは、通常用いられるものでもよく、パッドは
、脱脂綿その他各種の綿、不織布等を使用することがで
き、適宜その中央部をへこませた形状とすることができ
る。また、通常の方法により裏面を防水処理してもよい
。
[0017]
剥離シートは、塩化ビニル樹脂その他の合成樹脂等の材
質により成形され、中央部に円形、楕円形もしくは矩形
状のブリスター部を設け、また剥離シートをめくりやす
くするために端部にスリットを設けるのがよい。
[0018]
剥離シートのブリスター部下面には、薬剤を使用時まで
パッドに接触させるのを防止するための薬剤被覆膜がシ
ールしである。薬剤被覆膜はアルミ箔、グラシン紙等の
破壊されやすい膜が採用される。該被覆膜は、薬剤を保
護しうる大きさでよし)が、剥離シートの下面全体に設
けられていても差支えない。
[0019]That is, the emergency bandage of the present invention consists of an adhesive sheet attached with a pad and a release sheet, and the release sheet includes:
A blister portion whose lower surface is sealed with a drug coating film and which contains the drug is provided on the pad, and the blister portion is provided with a concave projection. [0011] When the emergency bandage of the present invention is used, the blister part is pressed with a finger to destroy the drug coating film by the concave projections of the blister part and move the drug to the pad. It is very easy to operate by placing your finger in the recessed part of the concave protrusion of the blister part, and since the protruding part is harder in shape than the surrounding part, if you press it from above, the protruding part will change its shape. The drug can reach the drug-coated membrane without breaking and easily and reliably destroy the drug-coated membrane at the desired location, which generally corresponds to the center of the pad. to the desired location without any waste. [0012] After the drug is transferred to the pad in this manner, the release sheet having the drug coating film and the blister portion provided with the concave protrusions is removed from the adhesive sheet. Further, since only the adhesive sheet having the pad with the drug applied thereto is applied to the wound, there is no danger or discomfort during use. [0013] Regarding the agents used in the present invention, chlorhexidine gluconate, benzalkonium chloride, chlorxylenol, acrinol, thianthol, dequalinium chloride, sulfisomidine, sulfamine, nitrofurazone, boric acid, homosulfamine, triclocarpane are used as disinfectants. Zinc oxide as a wound astringent healing promoter, etc.
Pyridoxine hydrochloride, tocopherol acetate, pyridoxine civalmitate, etc. Hemostatic agents include naphazoline hydrochloride,
Anti-inflammatory agents such as zinc sulfate and ephedrine hydrochloride; steroids such as prednisolone, dexamethasone, and cortisone acetate; glycyrrhetin and lysozyme chloride; and antihistamine agents such as chlorpheniramine maleate and diphenhydramine hydrochloride. [0014] Local narcotics include acupuncture, ethyl aminobenzoate, procaine hydrochloride, dypcaine hydrochloride, tetracaine hydrochloride, diethylaminoethyl valbutylaminobenzoate and the like. [0015] Depending on the purpose, these drugs can be used singly or as a combination of multiple drugs, and the drug may be in the form of a solution, or
It may be in any form as long as it is fluid, such as ointment, grease, or powder. [0016] The pressure-sensitive adhesive sheet may be one that is commonly used, and the pad may be made of absorbent cotton, various types of cotton, nonwoven fabric, etc., and may have a shape with a concave central portion as appropriate. Further, the back surface may be waterproofed by a normal method. [0017] The release sheet is molded from a material such as vinyl chloride resin or other synthetic resin, and has a circular, oval, or rectangular blister section in the center, and slits at the ends to make it easier to turn over the release sheet. It is good to have a [0018] A drug coating film is sealed on the lower surface of the blister of the release sheet to prevent the drug from coming into contact with the pad until use. As the drug coating membrane, a membrane that is easily destroyed, such as aluminum foil or glassine paper, is used. The coating film may be large enough to protect the drug) and may be provided on the entire lower surface of the release sheet. [0019]
以下、図面を参照して本発明をさらに詳細に説明する。
第1図は本発明の救急絆創膏の一実施例の断面図である
。
[0020]
図1において、1はパッド2を装着した粘着シートであ
り、パッド上部には薬剤3が、薬剤被覆膜5と剥離シー
ト4に設けれたブリスター部6との空間内に包含されて
いる。ブリスター部6には凹状の突起8が設げられてお
り、また剥離シート4の端部にはスリット7が刻設しで
ある。
[0021]
この救急絆創膏を使用する場合、ブリスター部6の凹状
突起8の窪み部分に指をかけて、凹状突起8をパッド2
に向けて押圧して、薬剤被覆膜5を破壊することにより
、薬剤3をパッド2上に移動させる。次いで、スリット
7を折り曲げ、剥離シート4を粘着シート1よりはがし
、新鮮な薬剤の付いたパッド2の部分を創傷面に当接使
用する。
[0022]
[発明の効果]
本発明の効果は次のとおりである。
(イ)薬剤被覆膜の破壊の容易性および確実性:本発明
の救急絆創膏はブリスター部に凹状の突起を有するため
、該凹状突起の窪み部分に指をかけて押圧することがで
き、ブリスター部の押圧操作がしやすく、そして突起部
分は形状的にその周辺部分より硬いため、これを上方よ
り押圧すれば突起部分は、その形状が壊れることなく薬
剤被覆膜に到達し、その所望の場所、一般的にはパッド
の中央部に対応する箇所の薬剤被覆膜を容易に、かつ確
実に破壊することができる。
(ロ)薬剤を無、駄なく使用することができる:上記し
たように、本発明の救急絆創膏においては、パッド上の
薬剤被覆膜の必要箇所を確実に破壊できるため、ブリス
ター内の薬剤はパッドの所望の場所に確実に移動し、従
って薬剤を無、駄なく使用することができる。
(ハ)傷口に対する安全性等:本発明の救急絆創膏にお
いては、薬剤をパッドに移動させた後、薬剤被覆膜およ
び凹状突起が設けられているブリスター部を有する剥離
シートは粘着シートから除去され、傷口には新鮮な薬剤
が付いたパッドを有する粘着シートのみが適用され、米
国特許第411841号明細書の絆創膏のように突起体
のような不要物が傷口部分に当接されることがないので
、傷口に対して違和感がなく、かつ安全に使用すること
ができ、殺菌、消毒、治療の所望の目的を有効に達成で
きるものである。Hereinafter, the present invention will be explained in more detail with reference to the drawings. FIG. 1 is a sectional view of an embodiment of the emergency bandage of the present invention. [0020] In FIG. 1, reference numeral 1 denotes an adhesive sheet on which a pad 2 is attached, and a drug 3 is contained in the space between a drug coating film 5 and a blister portion 6 provided on a release sheet 4 above the pad. ing. The blister portion 6 is provided with a concave projection 8, and the end of the release sheet 4 is provided with a slit 7. [0021] When using this emergency bandage, put your finger on the recessed part of the concave protrusion 8 of the blister part 6, and press the concave protrusion 8 into the pad 2.
The drug 3 is moved onto the pad 2 by pressing toward the pad 2 to destroy the drug coating film 5. Next, the slit 7 is bent, the release sheet 4 is peeled off from the adhesive sheet 1, and the part of the pad 2 with the fresh drug applied is brought into contact with the wound surface. [0022] [Effects of the Invention] The effects of the present invention are as follows. (b) Ease and certainty of breaking the drug coating film: Since the emergency bandage of the present invention has a concave protrusion in the blister portion, it is possible to press the concave part of the concave protrusion with a finger, and the blister It is easy to press the part, and the protruding part is harder in shape than its surrounding parts, so if it is pressed from above, the protruding part will reach the drug coating film without breaking its shape, and the desired coating will be applied. The drug coating film can be easily and reliably destroyed at a location, generally corresponding to the center of the pad. (b) Drugs can be used without waste: As mentioned above, in the emergency bandage of the present invention, the necessary parts of the drug coating film on the pad can be reliably destroyed, so the drugs in the blister can be used without wastage. The drug can be reliably moved to the desired location on the pad, so the drug can be used without waste. (c) Safety for wounds, etc.: In the emergency bandage of the present invention, after the drug is transferred to the pad, the drug coating film and the release sheet having the blister portion provided with concave projections are removed from the adhesive sheet. , only an adhesive sheet with a fresh drug-applied pad is applied to the wound, and unnecessary objects such as protrusions are not brought into contact with the wound as in the bandage of U.S. Pat. No. 4,118,841. Therefore, it does not feel uncomfortable on the wound, can be used safely, and can effectively achieve the desired purposes of sterilization, disinfection, and treatment.
【図1】 本発明の救急絆創膏の一実施例の断面図である。[Figure 1] FIG. 1 is a sectional view of an embodiment of the emergency bandage of the present invention.
粘着シート パッド 薬剤 剥離シート 薬剤被覆膜 ブリスター部 スリット 凹状突起 adhesive sheet pad drug release sheet drug coating membrane Blister part slit concave protrusion
【図1】 図面[Figure 1] drawing
Claims (1)
からなり、該剥離シートには、薬剤被覆膜によりその下
面がシールされ、かつ薬剤を包含するブリスター部が前
記パッド上に位置して設けられており、該ブリスター部
には凹状の突起が設けられている救急絆創膏。[Claim 1] Consisting of an adhesive sheet and a release sheet on which a pad is attached, the release sheet has a lower surface sealed with a drug coating film, and a blister portion containing the drug is provided on the pad. An emergency bandage, which has a concave protrusion on the blister portion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP41048790A JPH03247335A (en) | 1990-12-13 | 1990-12-13 | Emergency adhesive bandage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP41048790A JPH03247335A (en) | 1990-12-13 | 1990-12-13 | Emergency adhesive bandage |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP25559087A Division JPS63119764A (en) | 1987-10-09 | 1987-10-09 | Emergency adhesive plaster |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03247335A true JPH03247335A (en) | 1991-11-05 |
JPH0479663B2 JPH0479663B2 (en) | 1992-12-16 |
Family
ID=18519649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP41048790A Granted JPH03247335A (en) | 1990-12-13 | 1990-12-13 | Emergency adhesive bandage |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03247335A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61222451A (en) * | 1985-12-14 | 1986-10-02 | 日本臓器製薬株式会社 | Emergency bandage |
-
1990
- 1990-12-13 JP JP41048790A patent/JPH03247335A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61222451A (en) * | 1985-12-14 | 1986-10-02 | 日本臓器製薬株式会社 | Emergency bandage |
Also Published As
Publication number | Publication date |
---|---|
JPH0479663B2 (en) | 1992-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880003941Y1 (en) | First aid adhesive tape | |
US2579403A (en) | Medical bandage | |
US6120792A (en) | Medicated skin patch and method for its use | |
JP6275718B2 (en) | Integrated bandage device | |
AU2006333988B2 (en) | Adhesive patch | |
US3366112A (en) | Adhesive bandage having container of liquid medicament | |
JPH0556976B2 (en) | ||
US20040049144A1 (en) | Hypoallergenic bandage | |
US20160270968A1 (en) | Two-part bandage with replaceable wound covering portion | |
US3297032A (en) | Adhesive bandage having container of medicament carried by removable protector strip | |
KR20000063010A (en) | Adhesive bandage for first aid | |
WO2007048171A1 (en) | A medicated dressing for wound healing | |
JPH03247335A (en) | Emergency adhesive bandage | |
JPH0157580B2 (en) | ||
JPH061135Y2 (en) | First aid bandage | |
JPH04329951A (en) | Bandage for emergency | |
JPH0371900B2 (en) | ||
JPS63119764A (en) | Emergency adhesive plaster | |
KR880003940Y1 (en) | First Aid Band-Aid | |
JP4136182B2 (en) | Emergency bandage | |
JPS6319061Y2 (en) | ||
JPH0534649Y2 (en) | ||
JPH0432099Y2 (en) | ||
JPH0856982A (en) | Adhesive tape | |
JPS61222451A (en) | Emergency bandage |